Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

Share Price is delayed by 15 minutes
Get Live Data
212.50    -50.00 (-19.05%)
Bid:
210.00
Ask:
215.00
Spread: 5.00 (2.381%)
Market Cap: £63.91m
MPAC Live PriceLast checked at - London Stock Exchange

Intraday Mpac Group Plc Share Chart

Disposal

1 Jun 2015 07:00

RNS Number : 7096O
Molins PLC
01 June 2015
 



FOR IMMEDIATE RELEASE 1 June 2015

MOLINS PLC

 ("Molins" or the "Company" or the "Group")

Completion of Strategic Review of

Analytical Services Laboratory Operation

 

Molins, the international engineering and services company, announces that it is has entered into an agreement with Enthalpy Analytical, Inc ('Enthalpy'), an affiliate of Montrose Environmental Group, Inc, for the sale of the trade and certain assets of its US based analytical services laboratory operation Arista Laboratories, Inc ("Arista"), for a consideration of $0.5m (£0.3m), which was paid in cash on completion. The sale represents the conclusion of the Company's strategic review of this operation which commenced in February 2015 as previously reported.

 

In the year ended 31 December 2014 Arista generated revenues of £2.5m and incurred operating losses of £2.0m. The book value of its assets at 31 December 2014 was £2.8m. Enthalpy has assumed the obligations of the property lease of the premises from which Arista operates, the costs of which will be subsidised by the Group for a period of 18 months from completion, at a total cost of £0.4m payable in monthly amounts. The Group expects to incur a loss on this disposal of approximately £3.5m, of which £0.3m will be net cash payments, plus a £1.3m goodwill write-off.

 

As previously reported, trading in the rest of the Scientific Services division is more challenging than expected, with tobacco sector conditions remaining difficult. The Packaging Machinery division, however, continues to trade ahead of last year and with Arista being treated as a discontinued operation in 2015, the Board expects the underlying trading performance of the Group for the year to be slightly ahead of current expectations.

 

Enquiries:

Molins PLC

Tel: +44 (0)1908 246870

Dick Hunter, Chief Executive

David Cowen, Group Finance Director

 

Panmure Gordon (UK) Limited (NOMAD)

Tel: +44 (0)20 7886 2500

Hugh Morgan / Peter Steel - Corporate Finance

Tom Salvesen - Corporate Broking

 

KTZ Communications

Tel: +44 (0)20 3178 6378

Katie Tzouliadis

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISPGUUCAUPAGAB
Date   Source Headline
10th Sep 20247:00 amRNSHalf Year Results
15th Aug 20247:00 amRNSAcquisition of SIGA Vision Ltd
10th Jul 20247:00 amRNSTrading Update and Notice of Results
22nd May 202412:36 pmRNSFirst FREYR Battery Unit Cell Production Trial
15th May 20243:10 pmRNSResult of AGM
15th May 20247:00 amRNSAGM Statement
26th Apr 20247:35 amRNSSiSTEM pilot battery assembly line
17th Apr 20247:00 amRNSLaunch of ESG Report
9th Apr 20241:12 pmRNSGrant of Options
8th Apr 20242:15 pmRNSNotice of AGM
19th Mar 20247:00 amRNSFull Year Results
21st Feb 20247:00 amRNSEquity Development Investor Presentation
16th Feb 20247:00 amRNSNotice of Results
11th Jan 20247:00 amRNSFull Year Trading Update
4th Dec 202311:51 amRNSDirector/PDMR Shareholding
27th Nov 202311:36 amRNSDirector/PDMR Dealing
18th Oct 20232:42 pmRNSHolding(s) in Company
12th Oct 20237:00 amRNSAppointment of Joint Broker
22nd Sep 202311:19 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSHalf Year Results
17th Aug 20237:00 amRNSEquity Development Investor Webinar
11th Jul 20237:00 amRNSTrading Update and Notice of Results
30th May 202310:52 amRNSDirector/PDMR Shareholding
18th May 202311:17 amRNSResult of Annual General Meeting
17th May 20237:00 amRNSAGM Statement
2nd May 20234:37 pmRNSDirector/PDMR Transaction
6th Apr 20235:30 pmRNSAvailability of Annual Report and Notice of AGM
27th Mar 202310:53 amRNSDirector/PDMR Dealing
22nd Mar 20237:01 amRNSCEO succession
22nd Mar 20237:00 amRNSFull Year Results
20th Feb 20237:00 amRNSEquity Development Investor Presentation
17th Feb 20237:00 amRNSNotice of Results
16th Jan 20237:00 amRNSFull Year Trading Update
24th Oct 20222:20 pmRNSDirectorate Appointment
14th Oct 202210:58 amRNSReplacement - PDMR Dealing & Total Voting Rights
12th Oct 20224:59 pmRNSDirector/PDMR Dealing & Total Voting Rights
15th Sep 202212:50 pmRNSMpac signs FREYR framework agreement
13th Sep 20227:00 amRNSEquity Development Investor Presentation
9th Sep 20222:16 pmRNSDirector/PDMR Transaction
8th Sep 20227:00 amRNSHalf Year Result
11th Jul 20227:00 amRNSTrading Update and Notice of Results
24th Jun 20222:54 pmRNSAppointment of new auditor
10th Jun 20224:10 pmRNSGrant of Options
27th May 20222:56 pmRNSDirectors/PDMRs Dealing
25th May 20224:13 pmRNSHolding(s) in Company
19th May 20223:57 pmRNSEBT Subscription & Total Voting Rights
13th May 20224:25 pmRNSDirectors/PDMRs Dealing - Replacement
12th May 20224:46 pmRNSDirectors/PDMRs Dealing
4th May 20224:16 pmRNSResult of AGM
4th May 20227:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.